ELANCO ANIMAL HEALTH INC (ELAN)
US28414H1032 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.23B | -78.00M | -472.00M | -560.10M | 67.90M | |||
| Depreciation Amortization | 694.00M | 682.00M | 716.00M | 516.90M | 314.50M | |||
| Income Taxes - Deferred | -80.00M | -57.00M | -154.00M | -124.80M | 100.00K | |||
| Change In Working Capital | -300.00M | -462.00M | -87.00M | 165.70M | -227.70M | |||
| Other non cash items | 1.19B | 367.00M | 480.00M | -38.70M | 69.30M | |||
| OPERATING CASH FLOW | 271.00M | 452.00M | 483.00M | -41.00M | 224.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -154.00M | -184.00M | -197.00M | -310.90M | -197.40M | |||
| Other Investing Activity | -15.00M | 5.00M | -333.00M | -4.47B | -37.40M | |||
| INVESTING CASH FLOW | -169.00M | -179.00M | -530.00M | -4.78B | -234.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -77.00M | -502.00M | 177.00M | 3.85B | -121.10M | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 1.22B | 0.00 | |||
| Other Financing Activity | -6.00M | -47.00M | 33.00M | -118.70M | -183.70M | |||
| FINANCING CASH FLOW | -83.00M | -549.00M | 210.00M | 4.95B | -304.80M | |||
| Exchange Rate Effect | -12.00M | -17.00M | -31.00M | 26.60M | -16.90M | |||
| CHANGE IN CASH | 7.00M | -293.00M | 132.00M | 160.30M | -332.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 271.00M | 452.00M | 483.00M | -41.00M | 224.10M | |||
| Capital Expenditure | -154.00M | -184.00M | -197.00M | -310.90M | -197.40M | |||
| FREE CASH FLOW | 117.00M | 268.00M | 286.00M | -351.90M | 26.70M | |||
All data in USD